2Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med, 1995,333:555 -560.?A
3Jenkins SA, Shields R, Davies M, et al. A multicentre randomised trail comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut, 1997,41:526-533.?A
4Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology,2002,123:1013-1019.?A
5Sorbi D, Gostout C J, Peura D, et al. An assessment of the management of acute bleeding varices: a multicenter prospective memberbased study. Am J Gastroenterol,2003 ,98 :2424-2434.?A
6Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol,2000,95:768 -771.?A
7Freitas DS, Sofia C, Pontes JM, et al. Octrotide in acute bleeding esophageal varices: a prospective randomized study. Hepatogastroenterology, 2000,47:1310-1314.?A
8Bildozola M, Kravetz D, Argonz J, et al. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial.Scand J Gastroenterol, 2000,35:419-425.?A
9Corley DA, Cello JP, Adkisson W, et al. Octrotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology, 2001,120:946-954.?A
10Escorsell A, Banares R, Garcia-Pagan JC, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology,2002,35:385-392.?A
4Bildozola M, Kravetz D, Argonz J, et al. Efficacy of octreotide and sclcrotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prodpective, multicentric, and randomized clinical trial[J]. ScandJ Gastroenterol, 2000, 35(4):419.
6Boyanova L,Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents[J].Expert Review of Anticancer Therapy,2010.59-70.
7Torres-Debat ME,Pérez-Pérez G,Olivares A. Antimicrobial susceptibility of Helicobacter pylori and mechanisms of clarithromycin resistance in strains isolated from patients in Uruguay[J].Revista Espanola de Enfermedades Digestivas,2009.757-762.
